They are overextended and they need a means to cover their shorts before the EMA application is filed and accepted. A plan for an FDA application will make it even worse. They will not find that many shares, or even a significant percentage of them.
It’s just a coincidence that all these events happened so close together. I don’t see any hidden agendas by any “secret cabal” trying to destroy our company.
Someone thinks they have a legitimate grip and is angry about losing money.
Peer review is sorely needed to increase morale and put to bed some silly assumptions.
News 
Market Data 
Discover 
